ArticlePloS one2017

Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes.

Margarite D Matossian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.